No indication of increased infection rates using low-dose alemtuzumab instead of anti-thymocyte globulin as graft-versus-host disease prophylaxis before allogeneic stem cell transplantation-Reference-Cited by-同舟云学术

No indication of increased infection rates using low-dose alemtuzumab instead of anti-thymocyte globulin as graft-versus-host disease prophylaxis before allogeneic stem cell transplantation

Published:2017-12-27 Issue:1 Volume:20 Page:e12822
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Neumann Thomas¹^ORCID,Schneidewind Laila¹,Thiele Thomas²,Pink Daniel³,Schulze Meike⁴,Schmidt Christian¹,Krüger William¹

Affiliation:

1. Department of Haematology, Oncology, Transplantation; University Medical Centre; Ernst-Moritz-Arndt University; Greifswald Germany

2. Institute of Immunology and Transfusion Medicine; University Medical Centre; Ernst-Moritz-Arndt University; Greifswald Germany

3. Department of Haematology, Oncology; HELIOS Klinikum Bad Saarow; Bad Saarow Germany

4. Department of Internal Medicine; Wolgast Hospital; Wolgast Germany

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tid.12822/fullpdf

Reference37 articles.

1. Anti-human thymocyte globulin (ATG) for prophylaxis and treatment of graft-versus-host disease in recipients of allogeneic marrow grafts;Weiden;Transplant Proc,1978

2. A randomized study of the prevention of acute graft-versus-host disease;Ramsay;N Engl J Med,1982

3. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults;Theurich;Cochrane Database Syst Rev,2012

4. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: A randomised, open-label, multicentre phase 3 trial;Finke;Lancet Oncol,2009

5. CAMPATH: From concept to clinic;Waldmann;Philos Trans R Soc Lond B Biol Sci,2005

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epstein–Barr Virus Monitoring after an Allogeneic Hematopoietic Stem Cell Transplant: Review of the Recent Data and Current Practices in Canada;Current Oncology;2024-05-14

2. Factors Associated with Post-Transplant Active Epstein-Barr Virus Infection and Lymphoproliferative Disease in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review and Meta-Analysis;Vaccines;2021-03-19

3. Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models;PLOS ONE;2021-01-11

4. Graft-Versus-Host Disease (GvHD) Prophylaxis;Blood and Marrow Transplant Handbook;2021

5. Changing Definition of Immunosuppression: Targeted Therapies and Resulting Emerging Infections and Their Prevention;Emerging Transplant Infections;2021